agilon health, inc. (NYSE:AGL) Receives Consensus Recommendation of "Hold" from Analysts

agilon health, inc. (NYSE:AGL - Get Free Report) has been assigned an average rating of "Hold" from the eighteen research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $4.81.

A number of brokerages have weighed in on AGL. TD Cowen increased their price target on shares of agilon health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Citigroup raised agilon health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a report on Friday, March 21st. Finally, Royal Bank of Canada lifted their price objective on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a report on Wednesday, February 26th.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently added to or reduced their stakes in AGL. Oak Thistle LLC bought a new position in shares of agilon health in the fourth quarter valued at about $25,000. Ieq Capital LLC acquired a new position in shares of agilon health during the fourth quarter worth approximately $26,000. Signaturefd LLC grew its stake in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Humankind Investments LLC acquired a new stake in shares of agilon health in the fourth quarter valued at approximately $30,000. Finally, Raymond James Financial Inc. bought a new position in agilon health in the 4th quarter worth approximately $33,000.

agilon health Stock Performance

Shares of AGL stock traded up $0.23 during trading hours on Tuesday, reaching $4.16. 4,728,140 shares of the company's stock were exchanged, compared to its average volume of 4,862,022. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.72 billion, a P/E ratio of -4.43 and a beta of 0.38. The business has a fifty day moving average price of $4.23 and a 200-day moving average price of $3.16.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.